2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …

K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review

J Sanz, D Sánchez-Quintana, E Bossone… - Journal of the American …, 2019 - jacc.org
There is increasing recognition of the crucial role of the right ventricle (RV) in determining
functional status and prognosis in multiple conditions. The normal RV is anatomically and …

Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

A Chieffo, D Dudek, C Hassager… - … Heart Journal Acute …, 2021 - academic.oup.com
There has been a significant increase in the use of short-term percutaneous ventricular
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …

Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable …

HK Nordenswan, P Pöyhönen, J Lehtonen, K Ekström… - Circulation, 2022 - Am Heart Assoc
Background: Cardiac sarcoidosis (CS) predisposes to sudden cardiac death (SCD).
Guidelines for implantable cardioverter defibrillators (ICDs) in CS have been issued by the …

Multimodality Imaging of Right Heart Function: JACC Scientific Statement

RT Hahn, S Lerakis, V Delgado, K Addetia… - Journal of the American …, 2023 - jacc.org
Right ventricular (RV) size and function assessed by multimodality imaging are associated
with outcomes in a variety of cardiovascular diseases. Understanding RV anatomy and …

Assessment of the 2017 AHA/ACC/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis

F Kazmirczak, KHA Chen, S Adabag… - Circulation …, 2019 - Am Heart Assoc
Background: Implantable cardioverter-defibrillators are used to prevent sudden cardiac
death in patients with cardiac sarcoidosis. The most recent recommendations for …

Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis

M Aitken, M Davidson, MV Chan, C Urzua Fresno… - Radiology, 2023 - pubs.rsna.org
Background There is no consensus regarding the relative prognostic value of cardiac MRI
and fluorodeoxyglucose (FDG) PET in cardiac sarcoidosis. Purpose To perform a systematic …

[HTML][HTML] Management of cardiac sarcoidosis in 2020

N Gilotra, D Okada, A Sharma… - Arrhythmia & …, 2020 - ncbi.nlm.nih.gov
Sarcoidosis is an inflammatory granulomatous disease that can affect any organ. Up to one-
quarter of patients with systemic sarcoidosis may have evidence of cardiac involvement. The …

Ventricular arrhythmias in cardiac sarcoidosis

DR Okada, J Smith, A Derakhshan, Z Gowani, S Misra… - Circulation, 2018 - Am Heart Assoc
The diagnosis of cardiac sarcoidosis (CS), especially in cases where there is limited or no
extracardiac involvement, is challenging. Patients with CS are at increased risk of ventricular …

Cardiac sarcoidosis

P Mankad, B Mitchell, D Birnie, J Kron - Current cardiology reports, 2019 - Springer
Abstract Purpose of Review In this state-of-the-art review, we highlight our current
understanding of diagnosis, assessment, and management of cardiac sarcoidosis (CS) …